Brandon M. White

Autumn N. Nero

Gregory D. Miller

Gene Y. Kang

Michael R. Laing

Maria A. Stubbings

Christopher D. Jones

Andrew S. Chalson

F. Dominic Cerrito

Evangeline Shih

William C. Baton

Charles M. Lizza

Sarah Ann Sullivan

Gabriel P. Brier

Eric C. Stops

Matthew J. Hertko

David L. Moses

Marta Godecki

Brian J. Forsatz

Frank C. Calvosa

Cary Miller

John Galanek

Quentin Jorgensen

ANDA filing triggers Celgene suit over generic POMALYST®, targeting five patents covering `pomalidomide` dosing and formulations for multiple myeloma.

Prosecution History analysis

Examiner Search analysis

Invalidity Framework analysis

Name	Ratings
Quinn Emanuel Urquhart & Sullivan LLP	L5 A
F. Dominic Cerrito	L5 A
Eric C. Stops	L5 D
Evangeline Shih	L4 B
Andrew S. Chalson	L3 A
Frank C. Calvosa	L3 B
Brian J. Forsatz	L3 C
Gabriel P. Brier	L3 D
Marta Godecki	L2 B
John Galanek	L1 B
Quentin Jorgensen	-- -- --
Jones Day	L5 A
Matthew J. Hertko	L4 C
Cary Miller	L2 B
Saul Ewing LLP	L4 B
David L. Moses	L5 A
William C. Baton	L5 A
Charles M. Lizza	L5 A
Sarah Ann Sullivan	L5 A

Name	Ratings
Perkins Coie LLP	L5 A
Autumn N. Nero	L4 E
Brandon M. White	L3 B
Maria A. Stubbings	L1 C
Michael R. Laing	-- -- --
Christopher D. Jones	-- -- --
Rivkin Radler LLPLocal	L2 B
Gregory D. Miller	L5 A
Gene Y. Kang	L2 B

2:19-cv-15343

Celgene Corp v. DR Reddy's Laboratories Ltd